Associated Factors and Comorbidities of Airflow Limitation in Subjects Undergoing Comprehensive Health Examination in Japan – Survey of Chronic Obstructive Pulmonary Disease Patients Epidemiology in Japan (SCOPE- J)

References

• OmoriH, KaiseT, SuzukiT, HaganG. Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan. Int J Chron Obstruct Pulmon Dis. 2016;11:873–880.27217740
   PubMedGoogle Scholar
• OmoriH, HigashiN, NawaT, FukuiT, KaiseT, SuzukiT. Chronic cough and phlegm in subjects undergoing comprehensive health examination in Japan – survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan (SCOPE-J). Int J Chron Obstruct Pulmon Dis. 2020;15:765–773. doi:10.2147/COPD.S23756832346287
   PubMed Web of Science ®Google Scholar
• SalviSS, BarnesPJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733–743. doi:10.1016/S0140-6736(09)61303-919716966
   PubMed Web of Science ®Google Scholar
• LamprechtB, McBurnieMA, VollmerWM, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2011;139:752–763. doi:10.1378/chest.10-125320884729
   PubMed Web of Science ®Google Scholar
• MartinezCH, ManninoDM, DivoMJ. Defining COPD-related comorbidities, 2004-2014. Chronic Obstr Pulm Dis. 2014;1:51–63.28848811
   PubMedGoogle Scholar
• DivoMJ, CasanovaC, MarinJM, et al. COPD comorbidities network. Eur Respir J. 2015;46(3):640–650. doi:10.1183/09031936.0017161426160874
   PubMed Web of Science ®Google Scholar
• CamiciottoliG, BigazziF, MagniC, et al. Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:2229–2236. doi:10.2147/COPD.S11172427695310
   PubMed Web of Science ®Google Scholar
• TakahashiS, BetsuyakuT. The chronic obstructive pulmonary disease comorbidity spectrum in Japan differs from that in western countries. Respir Investig. 2015;53:259–270. doi:10.1016/j.resinv.2015.05.005
   PubMedGoogle Scholar
• SchwabP, DhamaneAD, HopsonSD, et al. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis. 2017;12:735–744. doi:10.2147/COPD.S11225628260880
   PubMed Web of Science ®Google Scholar
• ParkJH, LeeJK, HeoEU, KimDK, ChungJS. The effect of obesity on patients with mild chronic obstructive pulmonary disease: results from KNHANES 2010 to 2012. Int J Chron Obstruct Pulmon Dis. 2017;12:757–763. doi:10.2147/COPD.S12619228280320
   PubMed Web of Science ®Google Scholar
• JeongSH, LeeH, CarriereKC, et al. Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016;11:1857–1865. doi:10.2147/COPD.S10306327536097
   PubMed Web of Science ®Google Scholar
• DenizS, ŞengülA, AydemirY, EmreJC, ÖzhanMH. Clinical factors and comorbidities affecting the cost of hospital-treated COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:3023–3030. doi:10.2147/COPD.S12063727980399
   PubMed Web of Science ®Google Scholar
• BarnesPJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138:16–27. doi:10.1016/j.jaci.2016.05.01127373322
   PubMed Web of Science ®Google Scholar
• VanfleterenLEGW, SpruitMA, GroenenM, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187:728–735. doi:10.1164/rccm.201209-1665OC23392440
   PubMed Web of Science ®Google Scholar
• ChubachiS, SatoM, KameyamaN, et al. Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort. Respir Med. 2016;117:272–279. doi:10.1016/j.rmed.2016.07.00227492541
   PubMed Web of Science ®Google Scholar
• JonesPW, HardingG, BerryP, WiklundI, ChenWH, LeidyNK. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34:648–654. doi:10.1183/09031936.0010250919720809
   PubMed Web of Science ®Google Scholar
• RaghavanN, LamYM, WebbKA, et al. Components of the COPD assessment test (CAT) associated with a diagnosis of COPD in a random population sample. COPD. 2012;9:175–183. doi:10.3109/15412555.2011.65080222409441
   PubMedGoogle Scholar
• NishimuraK, MitsumaS, KobayashiA, et al. COPD and disease-specific health status in a working population. Respir Res. 2013;14:61. doi:10.1186/1465-9921-14-6123725096
   PubMed Web of Science ®Google Scholar
• MillerMR, HankinsonJ, BrusascoV, et al. Standardization of spirometry. Eur Respir J. 2005;26:319–338. doi:10.1183/09031936.05.0003480516055882
   PubMed Web of Science ®Google Scholar
• SasakiH, NakamuraM, KidaK, et al. Reference value of spirogram and arterial blood gas partial pressure in Japanese. J Jpn Respir Soc. 2001;39:1–17.
   Google Scholar
• Stuart-HarrisCH, CroftonJ, GilsonJC, et al. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet. 1965;285:775–779.
   Google Scholar
• Japan Society of Ningen Dock. Staging the severity. Available from https://www.ningen-dock.jp/wp/common/data/other/release/hainteikubun_120405.pdf. Accessed 331, 2020.
   Google Scholar
• MatsuoS, ImaiE, HorioM, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–992. doi:10.1053/j.ajkd.2008.12.03419339088
   PubMed Web of Science ®Google Scholar
• EverittBS. Commentary: classification and cluster analysis. BMJ. 1995;311(7004):535–536. doi:10.1136/bmj.311.7004.5357663208
   PubMed Web of Science ®Google Scholar
• MasudaS, OmoriH, OnoueA, et al. Comorbidities according to airflow limitation severity: data from comprehensive health examination in Japan. Environ Health Prev Med. 2017;22:13. doi:10.1186/s12199-017-0620-029165119
   PubMed Web of Science ®Google Scholar
• NishidaY, TakahashiY, TezukaK, et al. A comprehensive analysis of association of medical history with airflow limitation: a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2017;12:2363–2371. doi:10.2147/COPD.S13810328848337
   PubMed Web of Science ®Google Scholar
• VestboJ, HurdSS, AgustiAG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–365. doi:10.1164/rccm.201204-0596PP22878278
   PubMed Web of Science ®Google Scholar
• De TorresJP, MarinJM, CasanovaC, et al. Lung cancer in patients with chronic obstructive pulmonary disease: incidence and predicting factors. Am J Respir Crit Care Med. 2011;184:913–919. doi:10.1164/rccm.201103-0430OC21799072
   PubMed Web of Science ®Google Scholar
• FunakoshiY, OmoriH, MiharaS, MarubayashiT, KatohT. Association between airflow obstruction and the metabolic syndrome or its components in Japanese men. Inter Med. 2010;49:2093–2099. doi:10.2169/internalmedicine.49.3882
   PubMed Web of Science ®Google Scholar
• AtlantisE, FaheyP, CochraneB, SmithS. Bidirectional associations between clinically relevant depression or anxiety and COPD. Chest. 2013;144(3):766–777. doi:10.1378/chest.12-191123429910
   PubMed Web of Science ®Google Scholar
• MiyazakiM, NakamuraH, ChubachiS, et al. Analysis of comorbid factors that increase the COPD assessment test scores. Respir Res. 2014;15:13. doi:10.1186/1465-9921-15-1324502760
   PubMed Web of Science ®Google Scholar
• OmachiTA, BlancPD, ClamanDM, et al. Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med. 2012;13:476–483. doi:10.1016/j.sleep.2011.12.00722429651
   PubMed Web of Science ®Google Scholar
• RoglianiP, LucaG, LauroD. Chronic obstructive pulmonary disease and diabetes. COPD Res Pract. 2015;1:3. doi:10.1186/s40749-015-0005-y
   Google Scholar
• YehHC, PunjabiNM, WangNY, et al. Cross-sectional and prospective study of lung function in adults with type 2 diabetes. Diabetes Care. 2008;31:741–746. doi:10.2337/dc07-146418056886
   PubMed Web of Science ®Google Scholar
• GotoY, YokokawaH, FukudaH, NaitoT, HisaokaT, IsonumaH. Body mass index and waist circumference are independent risk factors for low vital capacity among Japanese participants of a health checkup: a single-institution cross-sectional study. Environ Health Prev Med. 2015;20:108–115.25477291
   PubMed Web of Science ®Google Scholar